Novavax rises on promising Ebola vaccine trial By: CNBC.com News July 21, 2015 at 09:39 AM EDT Novavax shares rose at Tuesday's market open after the bio-pharmaceutical firm said its Ebola vaccine showed promising early results. Read More >> Related Stocks: Gsk Plc ADR Inovio Pharma Johnson & Johnson Newlink Genetics Cor Novavax Inc